MDS Inc. Announces Appointment of William D. Anderson as Chair of Board of Directors
February 01 2010 - 8:05AM
PR Newswire (US)
TORONTO, Feb. 1 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE:
MDZ), a leading provider of products and services to the global
life-sciences markets, today announced the appointment of William
D. Anderson as Chair of the Company's Board of Directors. Mr.
Anderson, who joined the Board in February 2007, will continue to
serve as a member of the Company's Special Committee and steps down
as Chair of the Audit Committee. Robert W. Luba, a member of the
Board since 1996, has been appointed Chair of the MDS Audit
Committee. James S.A. MacDonald, who joined the MDS Board in
January 2004 and has served as Chair since November 2008, remains
on the Board and will serve as a member of the Audit Committee and
as Chair of the Company's Special Committee. Mr. Anderson is a
Chartered Accountant and a Corporate Director, having retired in
2005 after serving 14 years with BCE Inc. From 2001 to 2004, Mr.
Anderson was President of BCE Ventures, and from 1997 to 2000, was
Chief Financial Officer of BCE Inc. Mr. Anderson is also a director
of TransAlta Corporation and Gildan Activewear Inc. About MDS MDS
Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that
provides market-leading products and services that customers need
for the development of drugs and the diagnosis and treatment of
disease. MDS Inc. is a leading global provider of innovative
technologies for use in medical imaging and radiotherapeutics,
sterilization, and pharmaceutical contract research. MDS has more
than 2,400 highly skilled people in nine countries. Find out more
at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Inc. CONTACT: MEDIA: Janet Ko, (905) 267-4226,
; INVESTORS: Catherine Love, (905) 267-4230,
Copyright